Skip to main content
Salvage therapies for first relapse of SHH medulloblastoma in early childhood.
Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma.
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4.
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC.
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas.
EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma.
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.
Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.